Bio-Rad Laboratories, Inc. Class A BIO
NYSE · United States · Health Technology
$377.71-1.84 (-0.48%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | 2.62 | 1.75 | +49.9% | $651.00M | +4.3% | +3.9%$334.71→$347.86 |
| Q1 2026 | 2026-04-30 | 1.89 | 2.77 | -31.8% | — | — | -6.8%$275.15→$256.55 |
| Q4 2025 | 2026-02-12 | 2.51 | 2.57 | -2.3% | — | — | -12.6%$293.69→$256.56 |
| Q3 2025 | 2025-10-29 | 2.26 | 2.30 | -1.7% | — | — | -7.8%$330.42→$304.61 |
| Q4 2023 | 2024-02-15 | 3.10 | 2.87 | +8.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.